bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Table 5 from Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab
Authors: Keung Emily Z. , Burgess Melissa , Salazar Ruth , Parra Edwin R. , Rodrigues-Canales Jaime , Bolejack Vanessa , Van Tine Brian A. , Schuetze Scott M. , Attia Steven , Riedel Richard F. , Hu James , Okuno Scott H. , Priebat Dennis A. , Movva Sujana , Davis Lara E. , Reed Damon R. , Reuben Alexandre , Roland Christina L. , Reinke Denise , Lazar Alexander J. , Wang Wei-Lien , Wargo Jennifer A. , Tawbi Hussein A.
Published: April 2023

Comparison of tumor PD-L1 expression and tumor immune infiltrate between baseline biopsies and at 8 weeks on treatment (STS only)
Supplementary Table 2 from Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab
Authors: Keung Emily Z. , Burgess Melissa , Salazar Ruth , Parra Edwin R. , Rodrigues-Canales Jaime , Bolejack Vanessa , Van Tine Brian A. , Schuetze Scott M. , Attia Steven , Riedel Richard F. , Hu James , Okuno Scott H. , Priebat Dennis A. , Movva Sujana , Davis Lara E. , Reed Damon R. , Reuben Alexandre , Roland Christina L. , Reinke Denise , Lazar Alexander J. , Wang Wei-Lien , Wargo Jennifer A. , Tawbi Hussein A.
Published: April 2023

SARC028 tumor biopsies obtained at baseline and after 8 weeks treatment and associated patient response to pembrolizumab
Supplemental Figure S1 from Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination
Authors: Tu Yiming , Chen Zhenyao , Zhao Pengzhan , Sun Guangchi , Bao Zhongyuan , Chao Honglu , Fan Liang , Li Chong , You Yongping , Qu Yan , Chen Yun , Ji Jing
Published: April 2023

Supplemental Figure S1
Table S2 from Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator–activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue
Authors: Wilson Hannah E. , Rhodes Kacey K. , Rodriguez Daniel , Chahal Ikttesh , Stanton David A. , Bohlen Joseph , Davis Mary , Infante Aniello M. , Hazard-Jenkins Hannah , Klinke David J. , Pugacheva Elena N. , Pistilli Emidio E.
Published: April 2023

Table S2 provides all the information pertaining to the individual BC-PDOC mice used in this study.
Table S1 from Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator–activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue
Authors: Wilson Hannah E. , Rhodes Kacey K. , Rodriguez Daniel , Chahal Ikttesh , Stanton David A. , Bohlen Joseph , Davis Mary , Infante Aniello M. , Hazard-Jenkins Hannah , Klinke David J. , Pugacheva Elena N. , Pistilli Emidio E.
Published: April 2023

Table S1 shows the primer sequences used for qPCR in human and murine samples.
Supplemental legend from Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator–activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue
Authors: Wilson Hannah E. , Rhodes Kacey K. , Rodriguez Daniel , Chahal Ikttesh , Stanton David A. , Bohlen Joseph , Davis Mary , Infante Aniello M. , Hazard-Jenkins Hannah , Klinke David J. , Pugacheva Elena N. , Pistilli Emidio E.
Published: April 2023

Supplemental legend
Table S6 from Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression
Authors: Chakraborty Goutam , Armenia Joshua , Mazzu Ying Z. , Nandakumar Subhiksha , Stopsack Konrad H. , Atiq Mohammad O. , Komura Kazumasa , Jehane Lina , Hirani Rahim , Chadalavada Kalyani , Yoshikawa Yuki , Khan Nabeela A. , Chen Yu , Abida Wassim , Mucci Lorelei A. , Lee Gwo-Shu Mary , Nanjangud Gouri J. , Kantoff Philip W.
Published: April 2023

Supplementary Table S6
Figure S2 from Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer
Authors: Recondo Gonzalo , Mezquita Laura , Facchinetti Francesco , Planchard David , Gazzah Anas , Bigot Ludovic , Rizvi Ahsan Z. , Frias Rosa L. , Thiery Jean Paul , Scoazec Jean-Yves , Sourisseau Tony , Howarth Karen , Deas Olivier , Samofalova Dariia , Galissant Justine , Tesson Pauline , Braye Floriane , Naltet Charles , Lavaud Pernelle , Mahjoubi Linda , Abou Lovergne Aurélie , Vassal Gilles , Bahleda Rastilav , Hollebecque Antoine , Nicotra Claudio , Ngo-Camus Maud , Michiels Stefan , Lacroix Ludovic , Richon Catherine , Auger Nathalie , De Baere Thierry , Tselikas Lambros , Solary Eric , Angevin Eric , Eggermont Alexander M. , Andre Fabrice , Massard Christophe , Olaussen Ken A. , Soria Jean-Charles , Besse Benjamin , Friboulet Luc
Published: April 2023

Supplementary Figure 2: ALK secondary mutations (corresponding to main Figure 3).
Supplementary Figures from Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma
Authors: Indraccolo Stefano , Lombardi Giuseppe , Fassan Matteo , Pasqualini Lorenza , Giunco Silvia , Marcato Raffaella , Gasparini Alessandra , Candiotto Cinzia , Nalio Silvia , Fiduccia Pasquale , Fanelli Giuseppe Nicolò , Pambuku Ardi , Della Puppa Alessandro , D'Avella Domenico , Bonaldi Laura , Gardiman Marina Paola , Bertorelle Roberta , De Rossi Anita , Zagonel Vittorina
Published: April 2023

Supplementary Figures
Supplementary Data from Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer
Authors: Thorek Daniel L.J. , Ku Anson T. , Mitsiades Nicholas , Veach Darren , Watson Philip A. , Metha Dipti , Strand Sven-Erik , Sharma Sai Kiran , Lewis Jason S. , Abou Diane S. , Lilja Hans G. , Larson Steven M. , McDevitt Michael R. , Ulmert David
Published: April 2023

Supplementary figure 3
Supplementary Data from Harnessing Androgen Receptor Pathway Activation for Targeted Alpha Particle Radioimmunotherapy of Breast Cancer
Authors: Thorek Daniel L.J. , Ku Anson T. , Mitsiades Nicholas , Veach Darren , Watson Philip A. , Metha Dipti , Strand Sven-Erik , Sharma Sai Kiran , Lewis Jason S. , Abou Diane S. , Lilja Hans G. , Larson Steven M. , McDevitt Michael R. , Ulmert David
Published: April 2023

Supplementary figure legends
Supplementary Table 2 from Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion
Authors: Ryu Daeun , Kim Seok Jin , Hong Yourae , Jo Areum , Kim Nayoung , Kim Hee-Jin , Lee Hae-Ock , Kim Kihyun , Park Woong-Yang
Published: April 2023

DEGs of MPC clusters.
Supplementary Data from Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations
Authors: Rich Thereasa A. , Reckamp Karen L. , Chae Young Kwang , Doebele Robert C. , Iams Wade T. , Oh Michael , Raymond Victoria M. , Lanman Richard B. , Riess Jonathan W. , Stinchcombe Thomas E. , Subbiah Vivek , Trevarthen David R. , Fairclough Stephen , Yen Jennifer , Gautschi Oliver
Published: April 2023

Supplementary Data
Figure S5 from Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer
Authors: Corella Alexandra N. , Cabiliza Ordonio Ma Victoria Andrea , Coleman Ilsa , Lucas Jared M. , Kaipainen Arja , Nguyen Holly M. , Sondheim Daniel , Brown Lisha G. , True Lawrence D. , Lee John K. , MacPherson David , Nghiem Paul , Gulati Roman , Morrissey Colm , Corey Eva , Nelson Peter S.
Published: April 2023

Figure S5. Effects of ABT-263 and AZD-1775 combinations on SCNPC and ARPC cell lines.
Supplementary Figures S1-S4 from Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer
Authors: Nouri Mannan , Massah Shabnam , Caradec Josselin , Lubik Amy A. , Li Na , Truong Sarah , Lee Ahn R. , Fazli Ladan , Ramnarine Varune R. , Lovnicki Jessica M. , Moore Jackson , Wang Mike , Foo Jane , Gleave Martin E. , Hollier Brett G. , Nelson Colleen , Collins Colin , Dong Xuesen , Buttyan Ralph
Published: April 2023

Supplementary Figures S1-S4
Figure S1 from Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate Cancer
Authors: Corella Alexandra N. , Cabiliza Ordonio Ma Victoria Andrea , Coleman Ilsa , Lucas Jared M. , Kaipainen Arja , Nguyen Holly M. , Sondheim Daniel , Brown Lisha G. , True Lawrence D. , Lee John K. , MacPherson David , Nghiem Paul , Gulati Roman , Morrissey Colm , Corey Eva , Nelson Peter S.
Published: April 2023

Figure S1. Additional features of SCNTs
Figure S6 from Altered Gene Expression along the Glycolysis–Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer
Authors: Karasinska Joanna M. , Topham James T. , Kalloger Steve E. , Jang Gun Ho , Denroche Robert E. , Culibrk Luka , Williamson Laura M. , Wong Hui-Li , Lee Michael K.C. , O'Kane Grainne M. , Moore Richard A. , Mungall Andrew J. , Moore Malcolm J. , Warren Cassia , Metcalfe Andrew , Notta Faiyaz , Knox Jennifer J. , Gallinger Steven , Laskin Janessa , Marra Marco A. , Jones Steven J.M. , Renouf Daniel J. , Schaeffer David F.
Published: April 2023

Heatmap showing median gene expression levels (z-score) of genes involved in various pathways related to cellular metabolism. For each gene, within each of the four metabolic subgroups, expression values were assessed for significant deviation from zero using Wilcoxon signed rank test (mu = 0).
Figure S2 from Altered Gene Expression along the Glycolysis–Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer
Authors: Karasinska Joanna M. , Topham James T. , Kalloger Steve E. , Jang Gun Ho , Denroche Robert E. , Culibrk Luka , Williamson Laura M. , Wong Hui-Li , Lee Michael K.C. , O'Kane Grainne M. , Moore Richard A. , Mungall Andrew J. , Moore Malcolm J. , Warren Cassia , Metcalfe Andrew , Notta Faiyaz , Knox Jennifer J. , Gallinger Steven , Laskin Janessa , Marra Marco A. , Jones Steven J.M. , Renouf Daniel J. , Schaeffer David F.
Published: April 2023

Bar plot depicting the proportion of glycolytic and cholesterogenic genes in each of the three consensus clusters in different cancer types.
Supplementary Methods from Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer
Authors: Xiao Yi , Ma Ding , Zhao Shen , Suo Chen , Shi Jinxiu , Xue Meng-Zhu , Ruan Miao , Wang Hai , Zhao Jingjing , Li Qin , Wang Peng , Shi Leming , Yang Wen-Tao , Huang Wei , Hu Xin , Yu Ke-Da , Huang Shenglin , Bertucci François , Jiang Yi-Zhou , Shao Zhi-Ming
Published: April 2023

Supplementary Methods
Figure S7 from Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine
Authors: Wang Sabrina Z. , Poore Brad , Alt Jesse , Price Antoinette , Allen Sariah J. , Hanaford Allison R. , Kaur Harpreet , Orr Brent A. , Slusher Barbara S. , Eberhart Charles G. , Raabe Eric H. , Rubens Jeffrey A.
Published: April 2023

Flank tumor growth in response to DON and carboplatin
Figure S2 from Detection of NRG1 Gene Fusions in Solid Tumors
Authors: Jonna Sushma , Feldman Rebecca A. , Swensen Jeffrey , Gatalica Zoran , Korn Wolfgang M. , Borghaei Hossein , Ma Patrick C. , Nieva Jorge J. , Spira Alexander I. , Vanderwalde Ari M. , Wozniak Antoinette J. , Kim Edward S. , Liu Stephen V.
Published: April 2023

Figure S2 from Detection of NRG1 Gene Fusions in Solid Tumors
Tables S1-S3 from The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response
Authors: Law Henry C.-H. , Lagundžin Dragana , Clement Emalie J. , Qiao Fangfang , Wagner Zachary S. , Krieger Kimiko L. , Costanzo-Garvey Diane , Caffrey Thomas C. , Grem Jean L. , DiMaio Dominick J. , Grandgenett Paul M. , Cook Leah M. , Fisher Kurt W. , Yu Fang , Hollingsworth Michael A. , Woods Nicholas T.
Published: April 2023

Table S1: The demographics of the patients involved in the study, classified by stage at diagnosis. Table S2: The TMT labelling scheme of all 8 batches of samples. Table S3: The total list of proteins identified.
Figures S6-S10 from The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response
Authors: Law Henry C.-H. , Lagundžin Dragana , Clement Emalie J. , Qiao Fangfang , Wagner Zachary S. , Krieger Kimiko L. , Costanzo-Garvey Diane , Caffrey Thomas C. , Grem Jean L. , DiMaio Dominick J. , Grandgenett Paul M. , Cook Leah M. , Fisher Kurt W. , Yu Fang , Hollingsworth Michael A. , Woods Nicholas T.
Published: April 2023

Figure S6: Protein expression and gene ontology analysis related to PDAC subtypes. Figure S7: The characterization of Protein Cluster 1. Figure S8: The characterization of Protein Cluster 2. Figure S9: The characterization of Protein Cluster 3. Figure S10: The Kaplan-Meier curves of patients separated based on individual PDAC liver metastasis subtypes.
Supplementary Figure 4 from YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer – Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer
Authors: Li Fan , Xu Yan , Liu Bovey , Singh Pankaj Kumar , Zhao Wei , Jin Jiankang , Han Guangchun , Scott Ailing W. , Dong Xiaochuan , Huo Longfei , Ma Lang , Pizzi Melissa Pool , Wang Ying , Li Yuan , Harada Kazuto , Xie Min , Skinner Heath D. , Ding Sheng , Wang Linghua , Krishnan Sunil , Johnson Randy L. , Song Shumei , Ajani Jaffer A.
Published: April 2023

Supplemental Figure 4. Anti-tumor effects of combination inhibition of YAP1 and CDK6 as well as radiation therapy in mice bearing radiation resistant tumors.
Supplementary Figure 2 from YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer – Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer
Authors: Li Fan , Xu Yan , Liu Bovey , Singh Pankaj Kumar , Zhao Wei , Jin Jiankang , Han Guangchun , Scott Ailing W. , Dong Xiaochuan , Huo Longfei , Ma Lang , Pizzi Melissa Pool , Wang Ying , Li Yuan , Harada Kazuto , Xie Min , Skinner Heath D. , Ding Sheng , Wang Linghua , Krishnan Sunil , Johnson Randy L. , Song Shumei , Ajani Jaffer A.
Published: April 2023

Supplemental Figure 2. Association of YAP1 and CDK6 in chemo/radiation resistant tissues and cells.
Supplementary Figure 1 from YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer – Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer
Authors: Li Fan , Xu Yan , Liu Bovey , Singh Pankaj Kumar , Zhao Wei , Jin Jiankang , Han Guangchun , Scott Ailing W. , Dong Xiaochuan , Huo Longfei , Ma Lang , Pizzi Melissa Pool , Wang Ying , Li Yuan , Harada Kazuto , Xie Min , Skinner Heath D. , Ding Sheng , Wang Linghua , Krishnan Sunil , Johnson Randy L. , Song Shumei , Ajani Jaffer A.
Published: April 2023

Supplemental Figure 1. Correlation of YAP1 and CDK6 in 78 cases of ESCC and 71 cases of EAC from TCGA database.
Supplementary figure legend from Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy
Authors: Karches Clara H. , Benmebarek Mohamed-Reda , Schmidbauer Moritz L. , Kurzay Mathias , Klaus Richard , Geiger Martina , Rataj Felicitas , Cadilha Bruno L. , Lesch Stefanie , Heise Constanze , Murr Ramona , vom Berg Johannes , Jastroch Martin , Lamp Daniel , Ding Jian , Duewell Peter , Niederfellner Gerhard , Sustmann Claudio , Endres Stefan , Klein Christian , Kobold Sebastian
Published: April 2023

Supplementary figure legend
Supplementary Table S1 -S5 from Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients
Authors: Kobayashi Masato , Chung Jin-Sung , Beg Muhammad , Arriaga Yull , Verma Udit , Courtney Kevin , Mansour John , Haley Barbara , Khan Saad , Horiuchi Yutaka , Ramani Vijay , Harker David , Gopal Purva , Araghizadeh Farshid , Cruz Ponciano D. , Ariizumi Kiyoshi
Published: April 2023

Supplementary Table S1. Summary of MDSC analysis of metastatic cancer patents. aAll cancer patients are diagnosed as stage III or IV. Supplementary Table S2. Correlation of variables and expansion of DC-HIL+ MDSCs among colorectal cancer patients. Supplementary Table S3. % DC-HIL+ MDSC/PBMC in subgroups with vs. without radiotherapy. Supplementary Table S4. Reversing effects of anti-DC-HIL vs. anti-PDL1 mAb on MDSC suppressor function between two different treatments. Supplementary Table S5. DC-HIL and PDL1 expression in colorectal cancer tissues.
Supplementary Data from Oncolytic HSV–Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition
Authors: Otani Yoshihiro , Yoo Ji Young , Chao Samantha , Liu Joseph , Jaime-Ramirez Alena Cristina , Lee Tae Jin , Hurwitz Brian , Yan Yuanqing , Dai Hongsheng , Glorioso Joseph C. , Caligiuri Michael A. , Yu Jianhua , Kaur Balveen
Published: April 2023

Supplementary Methods and Supplementary Figure Legends
Supplementary Table 1 from Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity
Authors: Baro Marta , Lopez Sambrooks Cecilia , Quijano Amanda , Saltzman W. Mark , Contessa Joseph
Published: April 2023

List of antibodies used in the study
Figure S5 from Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies
Authors: Toledo Rodrigo A. , Garralda Elena , Mitsi Maria , Pons Tirso , Monsech Jorge , Vega Estela , Otero Álvaro , Albarran Maria I. , Baños Natalia , Durán Yolanda , Bonilla Victoria , Sarno Francesca , Camacho-Artacho Marta , Sanchez-Perez Tania , Perea Sofia , Álvarez Rafael , De Martino Alba , Lietha Daniel , Blanco-Aparicio Carmen , Cubillo Antonio , Domínguez Orlando , Martínez-Torrecuadrada Jorge L. , Hidalgo Manuel
Published: April 2023

Figure S5: A) Levels of phosphorylated ERK following treatment of the MDST8 colorectal cell line, expressing R1032Q VEGFR2, with different kinase inhibitors in the presence. B) Proliferation assays of Colo320 cell lines, stably expressing WT and R1032Q VEGFR2, upon treatment with TKIs. The expression of the VEGFR2 R1032Q hot-spot mutant in Colo320 cell lines (WT to KRAS/NRAS/BRAF/PIK3CA and mutated to TP53 and APC) increased sensitivity to cabozantinib.
Figure S2 from Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies
Authors: Toledo Rodrigo A. , Garralda Elena , Mitsi Maria , Pons Tirso , Monsech Jorge , Vega Estela , Otero Álvaro , Albarran Maria I. , Baños Natalia , Durán Yolanda , Bonilla Victoria , Sarno Francesca , Camacho-Artacho Marta , Sanchez-Perez Tania , Perea Sofia , Álvarez Rafael , De Martino Alba , Lietha Daniel , Blanco-Aparicio Carmen , Cubillo Antonio , Domínguez Orlando , Martínez-Torrecuadrada Jorge L. , Hidalgo Manuel
Published: April 2023

Figure S2: Read alignments from WES-cfDNA, showing somatic mutations in APC and TP53 genes.
Figure S2 from Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study
Authors: Bailly Clément , Carlier Thomas , Jamet Bastien , Eugene Thomas , Touzeau Cyrille , Attal Michel , Hulin Cyrille , Facon Thierry , Leleu Xavier , Perrot Aurore , Garderet Laurent , Macro Margaret , Caillot Denis , Moreau Philippe , Kraeber-Bodéré Françoise , Bodet-Milin Caroline
Published: April 2023

Two examples of Î"SUVmax measurements in patients with multiple myeloma on FDG-PET scans acquired at baseline and after three courses of RVD
Figure S1 from Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study
Authors: Bailly Clément , Carlier Thomas , Jamet Bastien , Eugene Thomas , Touzeau Cyrille , Attal Michel , Hulin Cyrille , Facon Thierry , Leleu Xavier , Perrot Aurore , Garderet Laurent , Macro Margaret , Caillot Denis , Moreau Philippe , Kraeber-Bodéré Françoise , Bodet-Milin Caroline
Published: April 2023

Disposition of patients
Tables S5-S6 from Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma
Authors: Amin-Mansour Ali , George Suzanne , Sioletic Stefano , Carter Scott L. , Rosenberg Mara , Taylor-Weiner Amaro , Stewart Chip , Chevalier Aaron , Seepo Sara , Tracy Adam , Getz Gad , Hornick Jason L. , Nucci Marisa R. , Quade Bradley , Demetri George D. , Raut Chandrajit P. , Garraway Levi A. , Van Allen Eliezer M. , Wagner Andrew J.
Published: April 2023

Supplementary Tables 5 and 6
Table S5 from Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation
Authors: Liu Chao , Sadat Sayed H. , Ebisumoto Koji , Sakai Akihiro , Panuganti Bharat A. , Ren Shuling , Goto Yusuke , Haft Sunny , Fukusumi Takahito , Ando Mizuo , Saito Yuki , Guo Theresa , Tamayo Pablo , Yeerna Huwate , Kim William , Hubbard Jacqueline , Sharabi Andrew B. , Gutkind J. Silvio , Califano Joseph A.
Published: April 2023

List of relatively enriched pathways corresponding to each oncogenic state forming the Onco-GPS map.
Figure S3 from Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel
Authors: Faramand Rawan , Jain Michael , Staedtke Verena , Kotani Hiroshi , Bai Renyuan , Reid Kayla , Lee Sae Bom , Spitler Kristen , Wang Xuefeng , Cao Biwei , Pinilla Javier , Lazaryan Aleksander , Khimani Farhad , Shah Bijal , Chavez Julio C. , Nishihori Taiga , Mishra Asmita , Mullinax John , Gonzalez Ricardo , Hussaini Mohammad , Dam Marian , Brandjes Brigett D. , Bachmeier Christina A. , Anasetti Claudio , Locke Frederick L. , Davila Marco L.
Published: April 2023

Validation of serum cytokine samples using the Ella with the Luminex.
Figure S2 from Targeting Super-Enhancer–Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor
Authors: Zhang Jiajun , Liu Weihai , Zou Changye , Zhao Zhiqiang , Lai Yuanying , Shi Zhi , Xie Xianbiao , Huang Gang , Wang Yongqian , Zhang Xuelin , Fan Zepei , Su Qiao , Yin Junqiang , Shen Jingnan
Published: April 2023

Comparative quantification of tumor weight and lung metastasis in CDK7 knockdown and control group.
Table S2 from Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy
Authors: Narasimhan Vignesh , Wright Josephine A. , Churchill Michael , Wang Tongtong , Rosati Rachele , Lannagan Tamsin R.M. , Vrbanac Laura , Richardson Anne B. , Kobayashi Hiroki , Price Timothy , Tye Gayle X.Y. , Marker Julie , Hewett Peter J. , Flood Michael P. , Pereira Shalini , Whitney G. Adam , Michael Michael , Tie Jeanne , Mukherjee Siddhartha , Grandori Carla , Heriot Alexander G. , Worthley Daniel L. , Ramsay Robert G. , Woods Susan L.
Published: April 2023

Patient characteristics & analyses.
Table S1, Figs. S1-3 from Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy
Authors: Jiang Shanshan , Eberhart Charles G. , Lim Michael , Heo Hye-Young , Zhang Yi , Blair Lindsay , Wen Zhibo , Holdhoff Matthias , Lin Doris , Huang Peng , Qin Huamin , Quinones-Hinojosa Alfredo , Weingart Jon D. , Barker Peter B. , Pomper Martin G. , Laterra John , van Zijl Peter C.M. , Blakeley Jaishri O. , Zhou Jinyuan
Published: April 2023

Table S1 lists the correlation coefficients of APTw intensity and pathologic indices. Fig. S1 shows quantitative analysis and diagnostic ability of rCBV. Fig. S2 shows anatomical and APTw MR images for a patient with treatment effect and a patient with recurrent tumor. Fig. S3 shows comparison between tumor volumes for three patients with treatment effects and 18 patients with recurrent tumor. Supplementary Results: Regression Analysis between APTw and Pathologic Indices
Figure S5 from Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy
Authors: Narasimhan Vignesh , Wright Josephine A. , Churchill Michael , Wang Tongtong , Rosati Rachele , Lannagan Tamsin R.M. , Vrbanac Laura , Richardson Anne B. , Kobayashi Hiroki , Price Timothy , Tye Gayle X.Y. , Marker Julie , Hewett Peter J. , Flood Michael P. , Pereira Shalini , Whitney G. Adam , Michael Michael , Tie Jeanne , Mukherjee Siddhartha , Grandori Carla , Heriot Alexander G. , Worthley Daniel L. , Ramsay Robert G. , Woods Susan L.
Published: April 2023

Extended peritonoid drug sensitivity data
Figure S3 from Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy
Authors: Narasimhan Vignesh , Wright Josephine A. , Churchill Michael , Wang Tongtong , Rosati Rachele , Lannagan Tamsin R.M. , Vrbanac Laura , Richardson Anne B. , Kobayashi Hiroki , Price Timothy , Tye Gayle X.Y. , Marker Julie , Hewett Peter J. , Flood Michael P. , Pereira Shalini , Whitney G. Adam , Michael Michael , Tie Jeanne , Mukherjee Siddhartha , Grandori Carla , Heriot Alexander G. , Worthley Daniel L. , Ramsay Robert G. , Woods Susan L.
Published: April 2023

Extended data peritonoid drug testing platform, patient specific responses
Table S1 to S3 from The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival
Authors: Santegoets Saskia J. , van Ham Vanessa J. , Ehsan Ilina , Charoentong Pornpimol , Duurland Chantal L. , van Unen Vincent , Höllt Thomas , van der Velden Lilly-Ann , van Egmond Sylvia L. , Kortekaas Kim E. , de Vos van Steenwijk Peggy J. , van Poelgeest Mariëtte I.E. , Welters Marij J.P. , van der Burg Sjoerd H.
Published: April 2023

Supplemental tables
Supplementary Figures from Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group
Authors: Laetsch Theodore W. , Roy Angshumoy , Xu Lin , Black Jennifer O. , Coffin Cheryl M. , Chi Yueh-Yun , Tian Jing , Spunt Sheri L. , Hawkins Douglas S. , Bridge Julia A. , Parsons D. Williams , Skapek Stephen X.
Published: April 2023

Supplementary Figures 1 and 2 Supplementary Figure 1: Representative photomicrographs of the spindle cell (A), round cell (B), and epithelioid (C) variants of undifferentiated sarcoma Supplementary Figure 2: GISTIC analysis of recurrent focal copy number alterations
Supplemental Figure Legends from Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy
Authors: Marciscano Ariel E. , Ghasemzadeh Ali , Nirschl Thomas R. , Theodros Debebe , Kochel Christina M. , Francica Brian J. , Muroyama Yuki , Anders Robert A. , Sharabi Andrew B. , Velarde Esteban , Mao Wendy , Chaudhary Kunal R. , Chaimowitz Matthew G. , Wong John , Selby Mark J. , Thudium Kent B. , Korman Alan J. , Ulmert David , Thorek Daniel L.J. , DeWeese Theodore L. , Drake Charles G.
Published: April 2023

Supplemental Figure Legends
Appendix from Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma
Authors: Figlin Robert A. , Tannir Nizar M. , Uzzo Robert G. , Tykodi Scott S. , Chen David Y.T. , Master Viraj , Kapoor Anil , Vaena Daniel , Lowrance William , Bratslavsky Gennady , DeBenedette Mark , Gamble Alicia , Plachco Ana , Norris Marcus S. , Horvatinovich Joe , Tcherepanova Irina Y. , Nicolette Charles A. , Wood Christopher G.
Published: April 2023

ADAPT study group and participating centers
Supplementary Data from CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer
Authors: Faisal Farzana A. , Murali Sanjana , Kaur Harsimar , Vidotto Thiago , Guedes Liana B. , Salles Daniela Correia , Kothari Vishal , Tosoian Jeffrey J. , Han Sumin , Hovelson Daniel H. , Hu Kevin , Spratt Daniel E. , Baras Alexander S. , Tomlins Scott A. , Schaeffer Edward M. , Lotan Tamara L.
Published: April 2023

Supplementary Figure S1
Table S2 from Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor–Positive Breast Cancer
Authors: Whittle James R. , Vaillant François , Surgenor Elliot , Policheni Antonia N. , Giner Göknur , Capaldo Bianca D. , Chen Huei-Rong , Liu He K. , Dekkers Johanna F. , Sachs Norman , Clevers Hans , Fellowes Andrew , Green Thomas , Xu Huiling , Fox Stephen B. , Herold Marco J. , Smyth Gordon K. , Gray Daniel H.D. , Visvader Jane E. , Lindeman Geoffrey J.
Published: April 2023

Differential gene enrichment from CRISPR-Cas9 genome-wide screens
Supplementary Appendix from Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
Authors: D'Agostino Mattia , Zaccaria Gian Maria , Ziccheddu Bachisio , Rustad Even H. , Genuardi Elisa , Capra Andrea , Oliva Stefania , Auclair Daniel , Yesil Jennifer , Colucci Paola , Keats Jonathan J. , Gambella Manuela , Bringhen Sara , Larocca Alessandra , Boccadoro Mario , Bolli Niccolò , Maura Francesco , Gay Francesca
Published: April 2023

Supplementary Appendix: Additional methods. Carfilzomib-treated patients - Trial design; Table S1. List and classification method of the analyzed variables; Table S2. Induction treatment classification; Table S3. List of the 21 genes analyzed and mutation frequency; Table S4. Distribution of upfront treatment and ASCT in CT subgroups; Table S5. Distribution of variables in Early PD vs reference population; Figure S1. Multivariate logistic regression model evaluating risk factors associated with death within 24 months; Figure S2. Sub-analysis on patients with or without baseline del(17p) and/or TP53 mutation; Figure S3. TP53 and IGLL5 mutations at diagnosis and at first relapse in available longitudinal samples; Figure S4. Epanechnikov kernel-smoothed estimated hazard rates of progressive disease (PD) over time; Figure S5. Comparison of Seq-FISH and conventional FISH in a subgroup of patients enrolled in clinical trials and analyzed in the same centralized laboratory.
Table S6 from Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression
Authors: Marcon Julian , DiNatale Renzo G. , Sanchez Alejandro , Kotecha Ritesh R. , Gupta Sounak , Kuo Fengshen , Makarov Vladimir , Sandhu Amar , Mano Roy , Silagy Andrew W. , Blum Kyle A. , Nassau Daniel E. , Benfante Nicole E. , Ortiz Michael V. , Carlo Maria I. , Chan Timothy A. , Motzer Robert J. , Voss Martin H. , Coleman Jonathan , Russo Paul , Reuter Victor , Hakimi A. Ari , Reznik Ed
Published: April 2023

Table S6 lists molecular features of the multiregional case
Figure S1 from Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression
Authors: Marcon Julian , DiNatale Renzo G. , Sanchez Alejandro , Kotecha Ritesh R. , Gupta Sounak , Kuo Fengshen , Makarov Vladimir , Sandhu Amar , Mano Roy , Silagy Andrew W. , Blum Kyle A. , Nassau Daniel E. , Benfante Nicole E. , Ortiz Michael V. , Carlo Maria I. , Chan Timothy A. , Motzer Robert J. , Voss Martin H. , Coleman Jonathan , Russo Paul , Reuter Victor , Hakimi A. Ari , Reznik Ed
Published: April 2023

Figure S1 displays the flow chart regarding the patient selection process on the MSK-IMPACT/Exome and TCGA-exome cohorts.
Supplementary Figure S1 from Deubiquitinase Activity Profiling Identifies UCHL1 as a Candidate Oncoprotein That Promotes TGFβ-Induced Breast Cancer Metastasis
Authors: Liu Sijia , González-Prieto Román , Zhang Mengdi , Geurink Paul P. , Kooij Raymond , Iyengar Prasanna Vasudevan , van Dinther Maarten , Bos Erik , Zhang Xiaobing , Le Dévédec Sylvia E. , van de Water Bob , Koning Roman I. , Zhu Hong-Jian , Mesker Wilma E. , Vertegaal Alfred C.O. , Ovaa Huib , Zhang Long , Martens John W.M. , ten Dijke Peter
Published: April 2023

Supplementary Figure S1. Related to Figure 1. A, LC-MS/MS analysis of in-gel tryptic digestion of excised gel slice indicated in figure 1D. iBAQ values (log2), sequence coverage, spectral count and number of peptides identified, of proteins identified by more than 2 peptides are indicated. B, Global profiling of DUB activity in tumor tissues from 52 patients.
Supplementary Tables from Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer
Authors: Vidula Neelima , Dubash Taronish , Lawrence Michael S. , Simoneau Antoine , Niemierko Andrzej , Blouch Erica , Nagy Becky , Roh Whijae , Chirn Brian , Reeves Brittany A. , Malvarosa Giuliana , Lennerz Jochen , Isakoff Steven J. , Juric Dejan , Micalizzi Douglas , Wander Seth , Spring Laura , Moy Beverly , Shannon Kristen , Younger Jerry , Lanman Richard , Toner Mehmet , Iafrate A. John , Getz Gad , Zou Lee , Ellisen Leif W. , Maheswaran Shyamala , Haber Daniel A. , Bardia Aditya
Published: April 2023

Supplemental tables
Figure S4 from Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy
Authors: Ladjohounlou Riad , Lozza Catherine , Pichard Alexandre , Constanzo Julie , Karam Jihad , Le Fur Pierre , Deshayes Emmanuel , Boudousq Vincent , Paillas Salomé , Busson Muriel , Le Blay Marion , Jarlier Marta , Marcatili Sara , Bardiès Manuel , Bruchertseifer Frank , Morgenstern Alfred , Torgue Julien , Navarro-Teulon Isabelle , Pouget Jean-Pierre
Published: April 2023

SUPPLEMENTARY FIG. S4. Signaling pathways activated in donor and recipient cells after exposure to 213Bi-anti-MISRII mAb alone or with MBCD.
Supplementary material 1. from Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target
Authors: Grellety Thomas , Callens Celine , Richard Elodie , Briaux Adrien , Vélasco Valérie , Pulido Marina , Gonçalves Anthony , Gestraud Pierre , MacGrogan Gaetan , Bonnefoi Hervé , Cardinaud Bruno
Published: April 2023

Antibody used for IHC asays.
Supplementary figure S3. from Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target
Authors: Grellety Thomas , Callens Celine , Richard Elodie , Briaux Adrien , Vélasco Valérie , Pulido Marina , Gonçalves Anthony , Gestraud Pierre , MacGrogan Gaetan , Bonnefoi Hervé , Cardinaud Bruno
Published: April 2023

Dose-response curves. Cell viability assay using MTT. Representation of dose-response curves of monotherapy in the 2 cell lines (MDA-MB-453 and SUM185PE) used to calculate IC50s based on 9 serial dilutions of the tested drugs. Y-axis: Cell survival (%); X- axis: log 10 [concentration], n=3-4.
Supplementary Data from A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers
Authors: Stevanović Sanja , Helman Sarah R. , Wunderlich John R. , Langhan Michelle M. , Doran Stacey L. , Kwong Mei Li M. , Somerville Robert P.T. , Klebanoff Christopher A. , Kammula Udai S. , Sherry Richard M. , Yang James C. , Rosenberg Steven A. , Hinrichs Christian S.
Published: April 2023

Figures for data supplement
Table S1 from CD45+CD326+ Cells are Predictive of Poor Prognosis in Non–Small Cell Lung Cancer Patients
Authors: Ishizawa Kota , Yamanaka Mie , Saiki Yuriko , Miyauchi Eisaku , Fukushige Shinichi , Akaishi Tetsuya , Asao Atsuko , Mimori Takahiro , Saito Ryota , Tojo Yutaka , Yamashita Riu , Abe Michiaki , Sakurada Akira , Pham Nhu-An , Li Ming , Okada Yoshinori , Ishii Tadashi , Ishii Naoto , Kobayashi Seiichi , Nagasaki Masao , Ichinose Masakazu , Tsao Ming-Sound , Horii Akira
Published: April 2023

Table S1. Patients' characteristics analyzed in this study
Figure S1 from CD45+CD326+ Cells are Predictive of Poor Prognosis in Non–Small Cell Lung Cancer Patients
Authors: Ishizawa Kota , Yamanaka Mie , Saiki Yuriko , Miyauchi Eisaku , Fukushige Shinichi , Akaishi Tetsuya , Asao Atsuko , Mimori Takahiro , Saito Ryota , Tojo Yutaka , Yamashita Riu , Abe Michiaki , Sakurada Akira , Pham Nhu-An , Li Ming , Okada Yoshinori , Ishii Tadashi , Ishii Naoto , Kobayashi Seiichi , Nagasaki Masao , Ichinose Masakazu , Tsao Ming-Sound , Horii Akira
Published: April 2023

Supplementary Figure S1. Genetic alterations of TP53 (exons 5 through 9) and KRAS (exon 2 containing codons 12 and 13) in Cases #1, 6, and 9 were Sanger sequenced; both strands were analyzed.
Figure S4 from Radiation with STAT3 Blockade Triggers Dendritic Cell–T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy
Authors: Ott Martina , Kassab Cynthia , Marisetty Anantha , Hashimoto Yuuri , Wei Jun , Zamler Daniel , Leu Jia-Shiun , Tomaszowski Karl-Heinz , Sabbagh Aria , Fang Dexing , Gupta Pravesh , Priebe Waldemar , Zielinski Rafal J. , Burks Jared K. , Long James P. , Kong Ling-Yuan , Fuller Gregory N. , DeGroot John , Sulman Erik P. , Heimberger Amy B.
Published: April 2023

Figure S4 shows representative p-STAT3 immunohistochemical staining.
Figure S1 from Radiation with STAT3 Blockade Triggers Dendritic Cell–T cell Interactions in the Glioma Microenvironment and Therapeutic Efficacy
Authors: Ott Martina , Kassab Cynthia , Marisetty Anantha , Hashimoto Yuuri , Wei Jun , Zamler Daniel , Leu Jia-Shiun , Tomaszowski Karl-Heinz , Sabbagh Aria , Fang Dexing , Gupta Pravesh , Priebe Waldemar , Zielinski Rafal J. , Burks Jared K. , Long James P. , Kong Ling-Yuan , Fuller Gregory N. , DeGroot John , Sulman Erik P. , Heimberger Amy B.
Published: April 2023

Figure S1 shows the IC50 for WP1066 in GL261 cells and the PK study for WP1066 in mice.
Supp Figure S1 from Serum Alpha-fetoprotein Levels and Clinical Outcomes in the Phase III CELESTIAL Study of Cabozantinib versus Placebo in Patients with Advanced Hepatocellular Carcinoma
Authors: Kelley Robin Kate , Meyer Tim , Rimassa Lorenza , Merle Philippe , Park Joong-Won , Yau Thomas , Chan Stephen L. , Blanc Jean-Frederic , Tam Vincent C. , Tran Albert , Dadduzio Vincenzo , Markby David W. , Kaldate Rajesh , Cheng Ann-Lii , El-Khoueiry Anthony B. , Abou-Alfa Ghassan K.
Published: April 2023

Figure S1. Forest plots of overall survival and progression-free survival by baseline AFP. Hazard ratios are stratified for the overall study population and unstratified for the subgroups.
Supplementary Data from Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer
Authors: Kettner Nicole M. , Vijayaraghavan Smruthi , Durak Merih Guray , Bui Tuyen , Kohansal Mehrnoosh , Ha Min Jin , Liu Bin , Rao Xiayu , Wang Jing , Yi Min , Carey Jason P.W. , Chen Xian , Eckols T. Kris , Raghavendra Akshara S. , Ibrahim Nuhad K. , Karuturi Meghan Sri , Watowich Stephanie S. , Sahin Aysegul , Tweardy David J. , Hunt Kelly K. , Tripathy Debu , Keyomarsi Khandan
Published: April 2023

Supplementary Data from Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer
Sup. M&M_sup Figure legends from The Proteome of Prostate Cancer Bone Metastasis Reveals Heterogeneity with Prognostic Implications
Authors: Iglesias-Gato Diego , Thysell Elin , Tyanova Stefka , Crnalic Sead , Santos Alberto , Lima Thiago S. , Geiger Tamar , Cox Jürgen , Widmark Anders , Bergh Anders , Mann Matthias , Flores-Morales Amilcar , Wikström Pernilla
Published: April 2023

Sup. M&M_sup Figure legends
Supplementary Materials and Methods from PARP Inhibition Suppresses GR–MYCN–CDK5–RB1–E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer
Authors: Liu Bo , Li Likun , Yang Guang , Geng Chuandong , Luo Yong , Wu Wenhui , Manyam Ganiraju C. , Korentzelos Dimitrios , Park Sanghee , Tang Zhe , Wu Cheng , Dong Zhenyang , Sigouros Michael , Sboner Andrea , Beltran Himisha , Chen Yu , Corn Paul G. , Tetzlaff Michael T. , Troncoso Patricia , Broom Bradley , Thompson Timothy C.
Published: April 2023

Supplementary Materials and Methods
Supplementary figures from Anti-Folate Receptor Alpha–Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer
Authors: Cheung Anthony , Opzoomer James , Ilieva Kristina M. , Gazinska Patrycja , Hoffmann Ricarda M. , Mirza Hasan , Marlow Rebecca , Francesch-Domenech Erika , Fittall Matthew , Dominguez Rodriguez Diana , Clifford Angela , Badder Luned , Patel Nirmesh , Mele Silvia , Pellizzari Giulia , Bax Heather J. , Crescioli Silvia , Petranyi Gyula , Larcombe-Young Daniel , Josephs Debra H. , Canevari Silvana , Figini Mariangela , Pinder Sarah , Nestle Frank O. , Gillett Cheryl , Spicer James F. , Grigoriadis Anita , Tutt Andrew N.J. , Karagiannis Sophia N.
Published: April 2023

Supplementary figures
Supplementary Figure S2 from Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer
Authors: Lee Jie , Chang Chih-Long , Lin Jhen-Bin , Wu Meng-Hao , Sun Fang-Ju , Jan Ya-Ting , Hsu Shih-Ming , Chen Yu-Jen
Published: April 2023

Kaplan-Meier curve demonstrating overall survival and cancer-specific survival for overall patients (n = 245) according to (A, B) pre-treatment skeletal muscle index, (C, D) pre-treatment skeletal muscle density , (E, F) subcutaneous adipose tissue index, (G, H) visceral adipose tissue index groups. SMD, skeletal muscle density; SMI, skeletal muscle index; SATI, subcutaneous adipose tissue index; VATI visceral adipose tissue index.
Combined Supplementary Data from FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Exhibits Low Toxicity and Antitumor Activity in Colorectal Cancer Models
Authors: Lakins Matthew A. , Koers Alexander , Giambalvo Raffaella , Munoz-Olaya Jose , Hughes Robert , Goodman Emma , Marshall Sylwia , Wollerton Francisca , Batey Sarah , Gliddon Daniel , Tuna Mihriban , Brewis Neil
Published: April 2023

All supplementary figures and tables within one powerpoint document
Supplementary Table 5 from CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status
Authors: Rubio Carolina , Martínez-Fernández Mónica , Segovia Cristina , Lodewijk Iris , Suarez-Cabrera Cristian , Segrelles Carmen , López-Calderón Fernando , Munera-Maravilla Ester , Santos Mirentxu , Bernardini Alejandra , García-Escudero Ramón , Lorz Corina , Gómez-Rodriguez Maria José , de Velasco Guillermo , Otero Irene , Villacampa Felipe , Guerrero-Ramos Felix , Ruiz Sergio , de la Rosa Federico , Domínguez-Rodríguez Sara , Real Francisco X. , Malats Núria , Castellano Daniel , Dueñas Marta , Paramio Jesus M.
Published: April 2023

Supplementary Table 5: Spreadsheet of transcriptomic data
Supplementary Table from Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid
Authors: Liu Yang , Pang Ying , Zhu Boqun , Uher Ondrej , Caisova Veronika , Huynh Thanh-Truc , Taieb David , Hadrava Vanova Katerina , Ghayee Hans Kumar , Neuzil Jiri , Levine Mark , Yang Chunzhang , Pacak Karel
Published: April 2023

Supplementary Table
Supplemental Figure 3 from Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid
Authors: Liu Yang , Pang Ying , Zhu Boqun , Uher Ondrej , Caisova Veronika , Huynh Thanh-Truc , Taieb David , Hadrava Vanova Katerina , Ghayee Hans Kumar , Neuzil Jiri , Levine Mark , Yang Chunzhang , Pacak Karel
Published: April 2023

Supplemental Figure 3
Supplemental Figure 2 from Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid
Authors: Liu Yang , Pang Ying , Zhu Boqun , Uher Ondrej , Caisova Veronika , Huynh Thanh-Truc , Taieb David , Hadrava Vanova Katerina , Ghayee Hans Kumar , Neuzil Jiri , Levine Mark , Yang Chunzhang , Pacak Karel
Published: April 2023

Supplemental Figure 2
Supplementary Figure Legends from Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection
Authors: Park Wungki , Chen Jiapeng , Chou Joanne F. , Varghese Anna M. , Yu Kenneth H. , Wong Winston , Capanu Marinela , Balachandran Vinod , McIntyre Caitlin A. , El Dika Imane , Khalil Danny N. , Harding James J. , Ghalehsari Nima , McKinnell Zoe , Chalasani Sree B. , Makarov Vladimir , Selenica Pier , Pei Xin , Lecomte Nicolas , Kelsen David P. , Abou-Alfa Ghassan K. , Robson Mark E. , Zhang Liying , Berger Michael F. , Schultz Nikolaus , Chan Timothy A. , Powell Simon N. , Reis-Filho Jorge S. , Iacobuzio-Donahue Christine A. , Riaz Nadeem , O'Reilly Eileen M.
Published: April 2023

Supplementary Figure Legends
Figure S7 from ΔNp63γ/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers
Authors: Srivastava Kirtiman , Pickard Adam , Craig Stephanie G. , Quinn Gerard P. , Lambe Shauna M. , James Jacqueline A. , McDade Simon S. , McCance Dennis J.
Published: April 2023

Figure S7 shows (A) protein expressions of total p63 and β-actin in Scram (control), UTR p63 and DBD p63 shRNA transfected E6/E7-HFK; (B) H&E staining of 3D-organotypic rafts established by the cells in (A); and (C) quantification of the number of invasive incidents across the rafts per cm established with these cells. (D) Protein expressions of total p63, Src-pY416, total Src, FAK-pY576/577, total FAK, Slug and β-actin in non-invasive cells expressing different p63 isoforms. Scale bars represented as 100μm. N=3 independent experiments. Data represented as mean {plus minus} s.e.m. and statistical significance calculated by One-way analysis of variance with **P<0.01 compared to the controls.
Supplementary Data Tables from A 15-Gene Immune, Stromal, and Proliferation Gene Signature that Significantly Associates with Poor Survival in Patients with Pancreatic Ductal Adenocarcinoma
Authors: Kandimalla Raju , Tomihara Hideo , Banwait Jasjit K. , Yamamura Kensuke , Singh Gagandeep , Baba Hideo , Goel Ajay
Published: April 2023

Supplementary tables
Supplementary Methods from Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma
Authors: Ishida Chiaki T. , Zhang Yiru , Bianchetti Elena , Shu Chang , Nguyen Trang T.T. , Kleiner Giulio , Sanchez-Quintero Maria J. , Quinzii Catarina M. , Westhoff Mike-Andrew , Karpel-Massler Georg , Prabhu Varun V. , Allen Joshua E. , Siegelin Markus D.
Published: April 2023

Supplementary Methods
Supplementary Data from GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer
Authors: O’Kane Grainne M. , Grünwald Barbara T. , Jang Gun-Ho , Masoomian Mehdi , Picardo Sarah , Grant Robert C. , Denroche Robert E. , Zhang Amy , Wang Yifan , Miller Jessica K. , Lam Bernard , Krzyzanowski Paul M. , Lungu Ilinca M. , Bartlett John M.S. , Peralta Melanie , Vyas Foram , Khokha Rama , Biagi James , Chadwick Dianne , Ramotar Stephanie , Hutchinson Shawn , Dodd Anna , Wilson Julie M. , Notta Faiyaz , Zogopoulos George , Gallinger Steven , Knox Jennifer J. , Fischer Sandra E.
Published: April 2023

Supplementary Data from GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer
Figure S5 from Inhibition of MAN2A1 Enhances the Immune Response to Anti–PD-L1 in Human Tumors
Authors: Shi Sailing , Gu Shengqing , Han Tong , Zhang Wubing , Huang Lei , Li Ziyi , Pan Deng , Fu Jingxin , Ge Jun , Brown Myles , Zhang Peng , Jiang Peng , Wucherpfennig Kai W. , Liu X. Shirley
Published: April 2023

Sup.Fig.5: Man2a1 knockout induced N-glycan composition change.
Supplementary Data from IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma
Authors: Chauvin Joe-Marc , Ka Mignane , Pagliano Ornella , Menna Carmine , Ding Quanquan , DeBlasio Richelle , Sanders Cindy , Hou Jiajie , Li Xian-Yang , Ferrone Soldano , Davar Diwakar , Kirkwood John M. , Johnston Robert J. , Korman Alan J. , Smyth Mark J. , Zarour Hassane M.
Published: April 2023

Supplemental Figure 3. TIGIT is internalized but not degraded upon binding to CD155.
Supplementary Document from Radiogenomic-Based Survival Risk Stratification of Tumor Habitat on Gd-T1w MRI Is Associated with Biological Processes in Glioblastoma
Authors: Beig Niha , Bera Kaustav , Prasanna Prateek , Antunes Jacob , Correa Ramon , Singh Salendra , Saeed Bamashmos Anas , Ismail Marwa , Braman Nathaniel , Verma Ruchika , Hill Virginia B. , Statsevych Volodymyr , Ahluwalia Manmeet S. , Varadan Vinay , Madabhushi Anant , Tiwari Pallavi
Published: April 2023

Supplementary Document